BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Friedman JM, Cornel MC, Goldenberg AJ, Lister KJ, Sénécal K, Vears DF; Global Alliance for Genomics and Health Regulatory and Ethics Working Group Paediatric Task Team. Genomic newborn screening: public health policy considerations and recommendations. BMC Med Genomics 2017;10:9. [PMID: 28222731 DOI: 10.1186/s12920-017-0247-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Gaille M, Araneda M, Dubost C, Guillermain C, Kaakai S, Ricadat E, Todd N, Rera M. Ethical and social implications of approaching death prediction in humans - when the biology of ageing meets existential issues. BMC Med Ethics 2020;21:64. [PMID: 32718352 DOI: 10.1186/s12910-020-00502-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Raz A, Timmermans S, Eyal G, Brothers K, Minari J. Challenges for precision public health communication in the era of genomic medicine. Genet Med 2022:S1098-3600(22)00776-6. [PMID: 35657379 DOI: 10.1016/j.gim.2022.05.010] [Reference Citation Analysis]
3 Boardman FK, Sadler C, Young PJ. Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population. Mol Genet Genomic Med. 2018;6:99-108. [PMID: 29169204 DOI: 10.1002/mgg3.353] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
4 Chan K, Petros M. Simple Test, Complex System: Multifaceted Views of Newborn Screening Science, Technology, and Policy. Glob Pediatr Health 2019;6:2333794X19894812. [PMID: 31903414 DOI: 10.1177/2333794X19894812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Burns BL, Bilkey GA, Coles EP, Bowman FL, Beilby JP, Pachter NS, Baynam G, Dawkins HJS, Weeramanthri TS, Nowak KJ. Healthcare System Priorities for Successful Integration of Genomics: An Australian Focus. Front Public Health 2019;7:41. [PMID: 30915324 DOI: 10.3389/fpubh.2019.00041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Powell SN, Byfield G, Bennetone A, Frantz AM, Harrison LK, James-crook ER, Osborne H, Owens TH, Shaw JL, O’daniel J, Milko LV. Parental Guidance Suggested: Engaging Parents as Partners in Research Studies of Genomic Screening for a Pediatric Population. Front Genet 2022;13:867030. [DOI: 10.3389/fgene.2022.867030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Best MC, Butow P, Jacobs C, Savard J, Biesecker B, Ballinger ML, Bartley N, Davies G, Napier CE, Smit AK, Thomas DM, Newson AJ; Members of the PiGeOn Project. Who should access germline genome sequencing? A mixed methods study of patient views. Clin Genet 2020;97:329-37. [PMID: 31674008 DOI: 10.1111/cge.13664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Fabie NAV, Pappas KB, Feldman GL. The Current State of Newborn Screening in the United States. Pediatr Clin North Am 2019;66:369-86. [PMID: 30819343 DOI: 10.1016/j.pcl.2018.12.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
9 Downie L, Halliday J, Lewis S, Amor DJ. Principles of Genomic Newborn Screening Programs: A Systematic Review. JAMA Netw Open 2021;4:e2114336. [PMID: 34283230 DOI: 10.1001/jamanetworkopen.2021.14336] [Reference Citation Analysis]
10 Farrell MH, Sims AM, La Pean Kirschner A, Farrell PM, Tarini BA. Vulnerable Child Syndrome and Newborn Screening Carrier Results for Cystic Fibrosis or Sickle Cell. J Pediatr 2020;224:44-50.e1. [PMID: 32826027 DOI: 10.1016/j.jpeds.2020.03.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Milko LV, Rini C, Lewis MA, Butterfield RM, Lin FC, Paquin RS, Powell BC, Roche MI, Souris KJ, Bailey DB Jr, Berg JS, Powell CM. Evaluating parents' decisions about next-generation sequencing for their child in the NC NEXUS (North Carolina Newborn Exome Sequencing for Universal Screening) study: a randomized controlled trial protocol. Trials 2018;19:344. [PMID: 29950170 DOI: 10.1186/s13063-018-2686-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
12 Hightower RM, Alexander MS. Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies. Muscle Nerve 2018;57:6-15. [PMID: 28877560 DOI: 10.1002/mus.25953] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
13 Starkweather A, Coleman B, Barcelona de Mendoza V, Fu M, Taylor J, Henderson W, Kenner C, Walker D, Amankwaa L, Anderson C. Policy brief: Improve coverage of newborn genetic screening to include the Recommended Uniform Screening Panel and newborn screening registry. Nurs Outlook 2017;65:480-4. [PMID: 28601255 DOI: 10.1016/j.outlook.2017.04.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Vidal-Folch N, Milosevic D, Majumdar R, Gavrilov D, Matern D, Raymond K, Rinaldo P, Tortorelli S, Abraham RS, Oglesbee D. A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening. J Mol Diagn 2017;19:755-65. [PMID: 28826609 DOI: 10.1016/j.jmoldx.2017.05.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
15 DeCristo DM, Milko LV, O'Daniel JM, Foreman AKM, Mollison LF, Powell BC, Powell CM, Berg JS. Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making. Genome Med 2021;13:50. [PMID: 33781310 DOI: 10.1186/s13073-021-00867-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Rahimzadeh V, Friedman JM, de Wert G, Knoppers BM. Exome/Genome-Wide Testing in Newborn Screening: A Proportionate Path Forward. Front Genet 2022;13:865400. [DOI: 10.3389/fgene.2022.865400] [Reference Citation Analysis]
17 Lynch PM. Colorectal Cancer Genetics Screening in the Community: Are We Ready? Can We Do It? Clin Gastroenterol Hepatol 2018;16:21-3. [PMID: 28987506 DOI: 10.1016/j.cgh.2017.09.049] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Smith EE, du Souich C, Dragojlovic N, Elliott AM; CAUSES Study, RAPIDOMICS Study. Genetic counseling considerations with rapid genome-wide sequencing in a neonatal intensive care unit. J Genet Couns 2019;28:263-72. [DOI: 10.1002/jgc4.1074] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
19 Wang H, Page R, Lopez D, Arkatkar S, Young C, Martinez D, Robbins-Furman P, Montalvo-Liendo N, Chen LS. Pregnant Latinas' views of adopting exome sequencing into newborn screening: A qualitative study. Genet Med 2022:S1098-3600(22)00741-9. [PMID: 35579624 DOI: 10.1016/j.gim.2022.04.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Shen EC, Srinivasan S, Passero LE, Allen CG, Dixon M, Foss K, Halliburton B, Milko LV, Smit AK, Carlson R, Roberts MC. Barriers and Facilitators for Population Genetic Screening in Healthy Populations: A Systematic Review. Front Genet 2022;13:865384. [DOI: 10.3389/fgene.2022.865384] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Hao C, Guo R, Hu X, Qi Z, Guo Q, Liu X, Liu Y, Sun Y, Zhang X, Jin F, Wu X, Cai R, Zeng D, Hu X, Wang X, Ji X, Li W, Xing Q, Mu L, Jiang X, Yang X, Yang W, Zhang Y, Yin Q, Ni X, Li W. Newborn screening with targeted sequencing: a multicenter investigation and a pilot clinical study in China. J Genet Genomics 2021:S1673-8527(21)00280-0. [PMID: 34474183 DOI: 10.1016/j.jgg.2021.08.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Blom M, Bredius RGM, van der Burg M. Future Perspectives of Newborn Screening for Inborn Errors of Immunity. Int J Neonatal Screen 2021;7:74. [PMID: 34842618 DOI: 10.3390/ijns7040074] [Reference Citation Analysis]
23 Onstwedder SM, Jansen ME, Leonardo Alves T, Cornel MC, Rigter T. Pursuing Public Health Benefit Within National Genomic Initiatives: Learning From Different Policies. Front Genet 2022;13:865799. [DOI: 10.3389/fgene.2022.865799] [Reference Citation Analysis]
24 White-Corey S, Peck JL, Pérez RI. Ethical implications of next-generation sequencing and the future of newborn screening. J Am Assoc Nurse Pract 2021;33:492-5. [PMID: 34196312 DOI: 10.1097/JXX.0000000000000631] [Reference Citation Analysis]
25 Peterlin A, Petrovič D, Peterlin B. Screening for Rare Genetic Variants Associated with Atherosclerosis: Opportunity for Personalized Medicine. Curr Vasc Pharmacol 2019;17:25-8. [PMID: 29412113 DOI: 10.2174/1570161116666180206111725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
26 Ferket BS, Baldwin Z, Murali P, Pai A, Mittendorf KF, Russell HV, Chen F, Lynch FL, Lich KH, Hindorff LA, Savich R, Slavotinek A, Smith HS, Gelb BD, Veenstra DL. Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods. Genet Med 2022:S1098-3600(22)00813-9. [PMID: 35833928 DOI: 10.1016/j.gim.2022.06.004] [Reference Citation Analysis]
27 Wright CF, FitzPatrick DR, Firth HV. Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet 2018;19:253-68. [PMID: 29398702 DOI: 10.1038/nrg.2017.116] [Cited by in Crossref: 172] [Cited by in F6Publishing: 134] [Article Influence: 43.0] [Reference Citation Analysis]
28 van Karnebeek CDM, Wortmann SB, Tarailo-Graovac M, Langeveld M, Ferreira CR, van de Kamp JM, Hollak CE, Wasserman WW, Waterham HR, Wevers RA, Haack TB, Wanders RJA, Boycott KM. The role of the clinician in the multi-omics era: are you ready? J Inherit Metab Dis 2018;41:571-82. [PMID: 29362952 DOI: 10.1007/s10545-017-0128-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 7.8] [Reference Citation Analysis]
29 Tutty E, Amor DJ, Jarmolowicz A, Paton K, Downie L. Personal utility of genomic sequencing for infants with congenital deafness. Am J Med Genet A 2021. [PMID: 34184819 DOI: 10.1002/ajmg.a.62411] [Reference Citation Analysis]
30 Johnston J, Lantos JD, Goldenberg A, Chen F, Parens E, Koenig BA; members of the NSIGHT Ethics and Policy Advisory Board. Sequencing Newborns: A Call for Nuanced Use of Genomic Technologies. Hastings Cent Rep 2018;48 Suppl 2:S2-6. [PMID: 30133723 DOI: 10.1002/hast.874] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
31 Christensen KD, Bernhardt BA, Jarvik GP, Hindorff LA, Ou J, Biswas S, Powell BC, Grundmeier RW, Machini K, Karavite DJ, Pennington JW, Krantz ID, Berg JS, Goddard KAB. Anticipated responses of early adopter genetic specialists and nongenetic specialists to unsolicited genomic secondary findings. Genet Med 2018;20:1186-95. [PMID: 29388940 DOI: 10.1038/gim.2017.243] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
32 Eichinger J, Elger BS, Koné I, Filges I, Shaw D, Zimmermann B, McLennan S. The full spectrum of ethical issues in pediatric genome-wide sequencing: a systematic qualitative review. BMC Pediatr 2021;21:387. [PMID: 34488686 DOI: 10.1186/s12887-021-02830-w] [Reference Citation Analysis]
33 Hohenfellner K, Elenberg E, Ariceta G, Nesterova G, Soliman NA, Topaloglu R. Newborn Screening: Review of its Impact for Cystinosis. Cells 2022;11:1109. [DOI: 10.3390/cells11071109] [Reference Citation Analysis]
34 Iskrov G, Ivanov S, Wrenn S, Stefanov R. Whole-Genome Sequencing in Newborn Screening-Attitudes and Opinions of Bulgarian Pediatricians and Geneticists. Front Public Health 2017;5:308. [PMID: 29250518 DOI: 10.3389/fpubh.2017.00308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 King JR, Hammarström L. Newborn Screening for Primary Immunodeficiency Diseases: History, Current and Future Practice. J Clin Immunol 2018;38:56-66. [PMID: 29116556 DOI: 10.1007/s10875-017-0455-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
36 Rajabi F. Updates in Newborn Screening. Pediatr Ann 2018;47. [DOI: 10.3928/19382359-20180426-01] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
37 King J, Ludvigsson J, Hammarström L. Newborn Screening for Primary Immunodeficiency Diseases: The Past, the Present and the Future. IJNS 2017;3:19. [DOI: 10.3390/ijns3030019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 Sen K, Harmon J, Gropman AL. Select Ethical Aspects of Next-Generation Sequencing Tests for Newborn Screening and Diagnostic Evaluation of Critically Ill Newborns. Int J Neonatal Screen 2021;7:76. [PMID: 34842609 DOI: 10.3390/ijns7040076] [Reference Citation Analysis]
39 Pichini A, Ahmed A, Patch C, Bick D, Leblond M, Kasperaviciute D, Deen D, Wilde S, Garcia Noriega S, Matoko C, Tuff-Lacey A, Wigley C, Scott RH. Developing a National Newborn Genomes Program: An Approach Driven by Ethics, Engagement and Co-design. Front Genet 2022;13:866168. [PMID: 35711926 DOI: 10.3389/fgene.2022.866168] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Zahed H, Sparks TN, Li B, Alsadah A, Shieh JTC. Potential Role of Genomic Sequencing in the Early Diagnosis of Treatable Genetic Conditions. J Pediatr 2017;189:222-226.e1. [PMID: 28947054 DOI: 10.1016/j.jpeds.2017.06.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
41 Lewis MA, Bonhomme N, Bloss CS. A New Era, New Strategies: Education and Communication Strategies to Manage Greater Access to Genomic Information. Hastings Cent Rep 2018;48 Suppl 2:S25-7. [PMID: 30133727 DOI: 10.1002/hast.880] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
42 Bailey DB Jr, Gehtland LM, Lewis MA, Peay H, Raspa M, Shone SM, Taylor JL, Wheeler AC, Cotten M, King NMP, Powell CM, Biesecker B, Bishop CE, Boyea BL, Duparc M, Harper BA, Kemper AR, Lee SN, Moultrie R, Okoniewski KC, Paquin RS, Pettit D, Porter KA, Zimmerman SJ. Early Check: translational science at the intersection of public health and newborn screening. BMC Pediatr 2019;19:238. [PMID: 31315600 DOI: 10.1186/s12887-019-1606-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
43 Bower A, Imbard A, Benoist JF, Pichard S, Rigal O, Baud O, Schiff M. Diagnostic contribution of metabolic workup for neonatal inherited metabolic disorders in the absence of expanded newborn screening. Sci Rep 2019;9:14098. [PMID: 31575911 DOI: 10.1038/s41598-019-50518-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
44 Esquerda M, Palau F, Lorenzo D, Cambra FJ, Bofarull M, Cusi V, Interdisciplinar En Bioetica G. Ethical questions concerning newborn genetic screening. Clin Genet 2021;99:93-8. [PMID: 32779199 DOI: 10.1111/cge.13828] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Mollison L, Berg JS. Genetic screening: birthright or earned with age? Expert Rev Mol Diagn 2017;17:735-8. [PMID: 28641021 DOI: 10.1080/14737159.2017.1346473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
46 Pereira S, Robinson JO, Gutierrez AM, Petersen DK, Hsu RL, Lee CH, Schwartz TS, Holm IA, Beggs AH, Green RC, McGuire AL; BabySeq Project Group. Perceived Benefits, Risks, and Utility of Newborn Genomic Sequencing in the BabySeq Project. Pediatrics 2019;143:S6-S13. [PMID: 30600265 DOI: 10.1542/peds.2018-1099C] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
47 Milko LV, O'Daniel JM, DeCristo DM, Crowley SB, Foreman AKM, Wallace KE, Mollison LF, Strande NT, Girnary ZS, Boshe LJ, Aylsworth AS, Gucsavas-Calikoglu M, Frazier DM, Vora NL, Roche MI, Powell BC, Powell CM, Berg JS. An Age-Based Framework for Evaluating Genome-Scale Sequencing Results in Newborn Screening. J Pediatr 2019;209:68-76. [PMID: 30851990 DOI: 10.1016/j.jpeds.2018.12.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]